GPI-anchored molecule-like protein (GML) expression in non-small cell lung cancer (NSCLC)

Anticancer Research

Volumn 19, Issue 5 B, 1999, Pages 4315-4319

  Komiya, Takefumi ^a,b   Hirashima, Tomonori ^a   Kikui, Masanori ^a   Fukuoka, Masahiro ^b   Ohno, Atsuko ^c   Kawase, Ichiro ^a  

^a OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c GIFU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chemosensitivity; Mutation; p53

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; MESSENGER RNA; PROTEIN P53;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0032763141     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. [Review]. Science 253: 49-53, 1991.
2. Lane DP: Cancer. p53, guardian of the genome. Nature 358: 15-16, 1992.
3. Furuhata T, Tokino T, Urano T and Nakamura Y: Isolation of a novel GPI-anchored gene specifically regulated by p53; correlation between its expression and anti-cancer drug sensitivity. Oncogene 13: 1965-1970, 1996.
4. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
5. Wu X, Bayle JH, Olson D and Levine AJ: The p53-mdm-2 autoregulatory feedback loop. Genes & Dev 7: 1126-1132, 1993.
6. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJJr.: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597, 1992.
7. Miyashita T and Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-9, 1995.
8. Kimura Y, Furuhata T, Urano T, Hirata K, Nakamura Y and Tokino T: Genomic structure and chromosomal localization of GML (GPI-anchored molecule-like protein), a gene induced by p53. Genomics 41: 477-480, 1997.
9. Kimura Y, Furuhata T, Shiratsuchi T, Nishimori H, Hirata K, Nakamura Y and Tokino T: GML sensitizes cancer cells to Taxol by induction of apoptosis. Oncogene 15: 1369-1374, 1997.
10. Masuda N, Fukuoka M, Takada M, Kudoh S and Kusunoki Y: Establishment and characterization of 20 human non-small cell lung cancer cell lines in a serum- free defined medium (ACL-4). Chest 100: 429-438, 1991.
11. Kubo A, Yoshikawa A, Hirashima T, Masuda N, Takada M, Takahara J, Fukuoka M, and Nakagawa K: Point mutations of the topoisomerase II alpha gene in patients with small cell lung cancer treated with etoposide. Cancer Res 56: 1232-1236, 1996.
12. Ohno A, Hirashima T, Kubo A, Masuda N, Takada M, Fujiwara H, Yasumitsu T, Kikui M, Fukuoka M and Nakagawa K: p53 status is associated with a favorable prognosis in patients with stage I-IIIa non-small cell lung cancer. Int J Oncol 10: 521-528, 1997.
13. Buchman VL, Chumakov PM, Ninkina NN, Samarina OP and Georgiev GP: A variation in the structure of the protein-coding region of the human p53 gene. Gene 70: 245-252, 1988.
14. Orita M, Iwahana H, Kanazawa H, Hayashi K and Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Pro Natil Acad Sci USA 86: 2766-2770, 1989.
15. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM and Rabbitts P: p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7: 1989-1997, 1992.
16. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994.
17. Kagawa K, Inoue T, Tokino T, Nakamura Y and Akiyama T: Overexpression of GML promotes radiation-induced cell cycle arrest and apoptosis. Biochem Biophys Res Commun 241: 481-485, 1997.
18. Nishimori H, Shiratsuchi T, Urano T, Kimura Y, Kiyono K, Tatsumi K, Yoshida S, Ono M, Kuwano M, Nakamura Y and Tokino T: A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 15: 2145-2150, 1997.